Hartmann Georgy, Cheung Annie K Y, Piquette-Miller Micheline
Faculty of Pharmacy, University of Toronto, Ontario, Canada.
J Pharmacol Exp Ther. 2002 Oct;303(1):273-81. doi: 10.1124/jpet.102.039404.
Endotoxin-mediated cholestasis stems from impaired hepatobiliary transport of bile acids and organic anions due to altered expression and activity of transporters, including Oatp, Mrp, Ntcp, and Bsep. However, the mechanisms by which the Oatp and Mrp genes are down-regulated are largely unknown. Using in vivo and in vitro murine models of inflammation, we examined the role of cytokines and bile acids in regulating Oatp and Mrp. Endotoxin (lipopolysaccharide, LPS), interleukin (IL)-6, IL-1beta, tumor necrosis factor (TNF)-alpha, cholic acid, taurocholate, or taurodeoxycholate was administered in vivo to mice or in vitro to Hepa 1-6 mouse hepatoma cells. Mrp, Oatp, and Bsep mRNA levels were measured by reverse transcription-polymerase chain reaction. Mrp efflux activity was measured using 5-carboxyfluorescein. In vivo, LPS treatment profoundly suppressed hepatic mRNA levels of Mrp2, Mrp3, Oatp1, Oatp2, and Bsep to 15, 60, 44, 30, and 32% of controls, respectively (p < 0.05), but did not significantly alter Mrp1 expression. IL-6 or IL-1beta administration suppressed Mrp2, Oatp1, Oatp2, and Bsep mRNA levels to 20 to 60% controls (p < 0.05). TNF-alpha administration affected mRNA levels of Mrp2, Mrp3, and Oatp2 but not Oatp1 or Bsep. Bile acid treatment increased the in vivo expression of Bsep but not Mrp or Oatp. Likewise, significantly lower mRNA levels of Mrp2 with a corresponding decrease in cellular efflux of 5-carboxyfluorescein was seen in vitro in IL-6- and IL-1beta-treated Hepa 1-6 cells, whereas bile acids did not have significant effects. In conclusion, cytokines are key mediators in regulating hepatic expression of anion transporters in inflammatory cholestasis, whereas bile acids likely play a minor role.
内毒素介导的胆汁淤积源于胆汁酸和有机阴离子的肝胆转运受损,这是由于转运蛋白(包括有机阴离子转运多肽(Oatp)、多药耐药相关蛋白(Mrp)、钠-牛磺胆酸共转运多肽(Ntcp)和胆汁盐输出泵(Bsep))的表达和活性改变所致。然而,Oatp和Mrp基因下调的机制在很大程度上尚不清楚。我们利用体内和体外小鼠炎症模型,研究了细胞因子和胆汁酸在调节Oatp和Mrp中的作用。将内毒素(脂多糖,LPS)、白细胞介素(IL)-6、IL-1β、肿瘤坏死因子(TNF)-α、胆酸、牛磺胆酸或牛磺去氧胆酸分别在体内给予小鼠,或在体外给予Hepa 1-6小鼠肝癌细胞。通过逆转录-聚合酶链反应测量Mrp、Oatp和Bsep的mRNA水平。使用5-羧基荧光素测量Mrp外排活性。在体内,LPS处理分别将Mrp2、Mrp3、Oatp1、Oatp2和Bsep的肝脏mRNA水平显著抑制至对照的15%、60%、44%、30%和32%(p<0.05),但未显著改变Mrp1的表达。给予IL-6或IL-1β可将Mrp2、Oatp1、Oatp2和Bsep的mRNA水平抑制至对照的20%至60%(p<0.05)。给予TNF-α影响Mrp2、Mrp3和Oatp2的mRNA水平,但不影响Oatp1或Bsep。胆汁酸处理增加了体内Bsep的表达,但未增加Mrp或Oatp的表达。同样,在体外,IL-6和IL-1β处理的Hepa 1-6细胞中,Mrp2的mRNA水平显著降低,同时5-羧基荧光素的细胞外排相应减少,而胆汁酸没有显著影响。总之,细胞因子是炎症性胆汁淤积中调节阴离子转运蛋白肝脏表达的关键介质,而胆汁酸可能起次要作用。